GALR3 and colorectal cancer: Reduced GAL2-R mRNA levels were observed in prostate, colorectal and breast cancer [35], while low expression of GAL3-R was reported to correlate with enhanced metastasis and lymph node invasion in colorectal cancer [31,32].